A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.
about
Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA.DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections.Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies
P2860
A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A novel antibody discovery pla ...... ies from human memory B cells.
@en
type
label
A novel antibody discovery pla ...... ies from human memory B cells.
@en
prefLabel
A novel antibody discovery pla ...... ies from human memory B cells.
@en
P2093
P2860
P1476
A novel antibody discovery pla ...... dies from human memory B cells
@en
P2093
Nicole Kallewaard
Partha S Chowdhury
Reena Varkey
William F Dall'Acqua
Xiaodong Xiao
P2860
P304
P356
10.1080/19420862.2016.1170263
P577
2016-04-06T00:00:00Z